EFFICACY OF INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK

QR Code

EFFICACY OF INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK

Objective: To determine the efficacy of induction chemotherapy in locally advanced squamous cell carcinoma of head and neck. Study Design: Descriptive case series. Place and Duration of Study: This study was conducted at the Department of Oncology, Combined Military Hospital (CMH) Rawalpindi,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Muhammad Imran Khan Wajid, Usman Ali, Umair Aslam Shahzad Khan, Shahid Rasul, Ahsan Mahmood, Salman Arif
Format:	article
Langue:	EN
Publié:	Army Medical College Rawalpindi 2019
Sujets:	squamous cell carcinoma induction chemotherapy Medicine R Medicine (General) R5-920
Accès en ligne:	https://doaj.org/article/4e9162f73c7b4aabaf8d38a63e9abf41
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
par: Yang Li, et autres
Publié: (2021)

Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era
par: Su Z, et autres
Publié: (2020)

Prognostic Value of Preoperative Mean Platelet Volume and a Predictive Nomogram in Oral Squamous Cell Carcinoma Patients Based on Real-World Data
par: Ning Y, et autres
Publié: (2021)

Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
par: Shinsuke Suzuki, et autres
Publié: (2021)

Outcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma
par: Minami S, et autres
Publié: (2016)

Hypoxia-Targeting Multifunctional Nanoparticles for Sensitized Chemotherapy and Phototherapy in Head and Neck Squamous Cell Carcinoma
par: Song C, et autres
Publié: (2020)

Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma
par: Hongfu Cai, et autres
Publié: (2021)

Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report
par: Shuluan Li, et autres
Publié: (2021)

New Trend of Surgery in Locally Advanced Esophageal Squamous Cell Carcinoma Patients
par: Tatcha Rerkrak, et autres
Publié: (2021)

OUTCOME OF CHEMOTHERAPY IN NON ACUTE PROMYELOCYTIC ACUTE MYELOID LEUKAEMIA
par: Nighat Shahbaz, et autres
Publié: (2020)

Efficacy and Safety of Concurrent Chemoradiotherapy Combined With Induction Chemotherapy or Adjuvant Chemotherapy in Patients With Stage II–IVA Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis and Meta-Analysis
par: Jie Yang, et autres
Publié: (2021)

Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia
par: Sarah Robinson, et autres
Publié: (2020)

Neoplasia blástica de células dendríticas plasmocitoides: Caso clínico
par: Tapia E,Oscar, et autres
Publié: (2012)

Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern era
par: Sarbani Ghosh-Laskar, et autres
Publié: (2020)

PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis
par: Xinxin Zhu, et autres
Publié: (2021)

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
par: Zhen Zeng, et autres
Publié: (2018)

A Comparative Study of Topicality and Writing Styles in Iranian and British Education Systems: The Cases of Deduction, Induction, and Quasi-induction
par: Mahmood Reza Moradian, et autres
Publié: (2020)

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy
par: Thomas M, et autres
Publié: (2017)

Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
par: Peng Yang, et autres
Publié: (2021)

Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy
par: Lv SH, et autres
Publié: (2021)

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
par: Xuanli Xu, et autres
Publié: (2021)

The effect of red-allotrope selenium nanoparticles on head and neck squamous cell viability and growth
par: Hassan CE, et autres
Publié: (2016)

New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas
par: Cristina Porcheri, et autres
Publié: (2021)

EFFICACY OF OLANZAPINE CONTAINING REGIMEN IN PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN PATIENTS OF BREAST CANCER RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY
par: Muhammad Umair, et autres
Publié: (2019)

Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
par: Philipp Baumeister, et autres
Publié: (2021)

IgG levels in Human Papillomavirus Infection Associated with Clinical Stage of Head and Neck Squamous Cell Carcinoma
par: Yussy Afriani Dewi, et autres
Publié: (2021)

Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
par: Farzaneh Kordbacheh, et autres
Publié: (2021)

A Novel Pyroptosis-Related Gene Signature for Prognostic Prediction of Head and Neck Squamous Cell Carcinoma
par: Qian X, et autres
Publié: (2021)

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial
par: Mitsuro Kanda, et autres
Publié: (2021)

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
par: Xing-xing Huo, et autres
Publié: (2021)

AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling
par: Fu L, et autres
Publié: (2021)

Prevalence of HPV in Mexican Patients with Head and Neck Squamous Carcinoma and Identification of Potential Prognostic Biomarkers
par: Galo Méndez-Matías, et autres
Publié: (2021)

Comparison of the pre-treatment functional MRI metrics’ efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy
par: Da-wei Zhao, et autres
Publié: (2021)

REMISSION RATE OF PRE-B ALL (ACUTE LYMPHOBLASTIC LEUKEMIA) AFTER INDUCTION CHEMOTHERAPY FOLLOWING UNITED KINGDOM ACUTE LYMPHOBLASTIC LEUKAEMIA 2011 (UKALL 2011) TRIAL PROTOCOL
par: Hafiz Muhammad Murtaza, et autres
Publié: (2021)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
par: Treewut Rassamegevanon, et autres
Publié: (2021)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
par: Xinwen Wang, et autres
Publié: (2021)

Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review
par: Lucrezia Togni, et autres
Publié: (2021)

Acantholytic Squamous Cell Carcinoma
par: Sandy Maganito, et autres
Publié: (2021)

Current Omics Trends in Personalised Head and Neck Cancer Chemoradiotherapy
par: Loredana G. Marcu, et autres
Publié: (2021)

Chemotherapy research and practice